NEWS

Webinar replay - From vision to reality

LINNC ASIA 2024: A bittersweet end to a wonderful conference

LINNC ASIA 2024: day 1 highlights uncovered

The legacy of Dr. Nick Hopkins

From vision to reality: live webinar

Revealing breakthroughs in sidewall aneurysm treatments

Double Solitaire™ for ACA and MCA stroke

Intracranial stenosis: double stenting thrombectomy & PTA

MicroVention Rebrands to Terumo Neuro – Reflects Expanded Focus and Stra...

ALISO VIEJO, Calif.--( BUSINESS WIRE )--MicroVention, Inc., a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today announced its official rebranding to Terumo Neuro, effective immediately. This name change signifies a new chapter in the company’s evolution while maintaining its unwavering commitment to the creation and commercialization of groundbreaking innovations in neurovascular care.  

Vesalio launches pVasc Thrombectomy System in the U.S. for peripheral oc...

Introducing pVasc™ mechanical thrombectomy system for the safe and effective non-surgical removal of occlusions from the peripheral vasculature Plano, Texas - (September 4, 2024)Vesalio announces the U.S. commercialization of pVasc™ Thrombectomy System for non-surgically removing peripheral occlusions. pVasc targets the full range of embolisms from soft, acute clots to fibrin-rich, calcified ones, enabling a fast and safe removal. Its unique Drop Zone™ technology traps, retains and securely removes thrombus to restore flow in patients suffering from acute limb ischemia (ALI) and other conditions related to peripheral artery disease (PAD).